Idamycin and Myelosuppression - a phase IV clinical study of FDA data

Summary:

Myelosuppression is reported as a side effect among people who take Idamycin (idarubicin hydrochloride), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Fludara, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Myelosuppression when taking Idamycin. It is created by eHealthMe based on reports of 548 people who have side effects when taking Idamycin from the FDA, and is updated regularly.

What is Idamycin?

Idamycin has active ingredients of idarubicin hydrochloride. eHealthMe is studying from 548 Idamycin users. Check the latest studies of Idamycin.

What is Myelosuppression?

Myelosuppression (a decrease in the production of blood cells) is found to be associated with 541 drugs and 210 conditions by eHealthMe. Check the latest studies of Myelosuppression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

548 people reported to have side effects when taking Idamycin.
Among them, 14 people (2.55%) have Myelosuppression.

Among these 14 people:

How long have people been on Idamycin when they have Myelosuppression? *

What is the gender of people who have Myelosuppression when taking Idamycin? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Myelosuppression when taking Idamycin? *

What are other drugs people take besides Idamycin? *

What are other side effects people have besides Myelosuppression? *

Fever: 6 people, 42.86%
Infection: 3 people, 21.43%
Rashes (redness): 3 people, 21.43%
Thrombocytopenia (decrease of platelets in blood): 2 people, 14.29%
Aspartate Aminotransferase Abnormal: 2 people, 14.29%
C-Reactive Protein Increased: 2 people, 14.29%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 14.29%
Electrocardiogram Qt Prolonged: 2 people, 14.29%
Herpes Zoster: 2 people, 14.29%
Methicillin-Resistant Staphylococcal Aureus Infection: 2 people, 14.29%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 35.71%
Chemotherapy Cardiotoxicity Attenuation: 3 people, 21.43%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 14.29%
Aspartate Aminotransferase Abnormal: 2 people, 14.29%
Alanine Aminotransferase Abnormal: 2 people, 14.29%
Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 2 people, 14.29%
Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Idamycin and have Myelosuppression?

- Check whether Myelosuppression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Idamycin:

Idamycin (548 reports)

Myelosuppression treatments and more:

Myelosuppression (18,470 reports)

Browse all side effects of Idamycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Myelosuppression:

Myelosuppression (541 drugs)

Browse all the conditions that are associated with Myelosuppression:

Myelosuppression (210 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on idarubicin hydrochloride (the active ingredients of Idamycin) and Idamycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.